Vireo Growth (VREOF) Depreciation and Depletion (2020 - 2026)

Vireo Growth (VREOF) reported Depreciation and Depletion of $1.1 million for Q1 2026, up 1000.0% on a YoY basis from $100000.0 in Q1 2025, and down 89.34% sequentially from $10.3 million in Q4 2025.

Vireo Growth (VREOF) Depreciation and Depletion (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Depreciation and Depletion data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation and Depletion rose 1000.0% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.4 million (up 3772.97% YoY), and the FY2025 full-year result was $11.3 million, up 3773.53% from the prior year.
  • Depreciation and Depletion slipped to $1.1 million in Q1 2026, from $10.3 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $10.3 million in Q4 2025 to a low of $69931.0 in Q4 2024.
  • A 5-year average of $816247.9 and a median of $156096.0 in 2022 frame the typical range for Depreciation and Depletion.
  • Across the five-year window, Depreciation and Depletion slumped 53.89% in 2024 and surged 14657.85% in 2025, its largest moves.
  • Tracing VREOF's Depreciation and Depletion over 5 years: stood at $165913.0 in 2022, then sank by 44.05% to $92827.0 in 2023, then fell by 24.67% to $69931.0 in 2024, then surged by 14657.85% to $10.3 million in 2025, then slumped by 89.34% to $1.1 million in 2026.
  • Business Quant data shows VREOF's Depreciation and Depletion at $1.1 million in Q1 2026, $10.3 million in Q4 2025, and $552589.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 36.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 21.60 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 28.00 Mn
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 10.32 Mn
Dec 31, 2025 10.32 Mn
Sep 30, 2025 552,589.00
Sep 30, 2025 552,589.00
Jun 30, 2025 387,596.00
Jun 30, 2025 387,596.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 69,931.00
Dec 31, 2024 69,931.00
Sep 30, 2024 76,292.00
Sep 30, 2024 76,292.00
Jun 30, 2024 72,925.00
Jun 30, 2024 72,925.00
Mar 31, 2024 73,547.00
Mar 31, 2024 73,547.00
Dec 31, 2023 92,827.00
Dec 31, 2023 92,827.00